AI MARKET SCANNING

$INTS

Intensity Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP-1.14%
MAX GAP RECORD-9.56%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $INTS

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $INTS

AI REPORT
Sep 15

VRA Earnings Gap Anticipation: A Deep Dive into Market Sentiment

VRA Earnings Preview: What Investors Need to KnowAs the markets grapple with the latest developments in AI-driven sectors,…
VIEW REPORT_
AI REPORT
Sep 13

This Week in Quant: A Deeper Dive into Market Dynamics

Analysis Markets this week exhibited a mix of volatility and strategic positioning as participants adapted to shifting macroeconomic…
VIEW REPORT_
AI REPORT
Sep 11

Mastering Portfolio Strategy: Navigating Market Uncertainties

Analysis Markets are at a crossroads as geopolitical tensions, economic uncertainties, and shifting investor sentiment converge. In this…
VIEW REPORT_